$HCMC Balance Sheet | Understand Stock

$HCMC

$0.00 +$0.00 (0.0%) Close

$HCMC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
CURRENT ASSETS
Cash
Cash and cash equivalent
Accounts receivable, net
Notes receivable
Inventories
Prepaid expenses and vendor deposits
Investment
Assets held for sale
Other current assets
Restricted cash
Current assets of discontinued operations
TOTAL CURRENT ASSETS

Restricted cash
Property, plant, and equipment, net of accumulated depreciation
Intangible assets, net of accumulated amortization
Goodwill
Note receivable
Right of use asset – operating lease, net
Other assets
Other assets of discontinued operations
TOTAL ASSETS

LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued expenses
Contingent consideration
Contract liabilities
Line of credit
Loan payable, current
Operating lease liability, current
Due to related party
Related Party
Total due to related party
Current liabilities of discontinued operations
TOTAL LIABILITIES

Loan payable, net of current portion
Due to related party
Operating lease liability, net of current
Other Long-term Liabilities of Discontinued Operations
TOTAL LIABILITIES
CONVERTIBLE PREFERRED STOCK
Series E redeemable convertible preferred stock, $1,000 par value per share, 14,722 shares authorized, 1,111 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; aggregate liquidation preference of $1.1 million as of June 30, 2026 and December 31, 2025, respectively.
STOCKHOLDERS’ DEFICIT
Series D convertible preferred stock, $1,000 par value per share, 5,000 shares authorized; 0 and 800 shares issued and outstanding as of December 31, 2023 and 2022, respectively.
Series C Convertible Preferred Stock
Series D Convertible Preferred Stock
Total series D convertible preferred stock, $1,000 par value per share, 5,000 shares authorized; 0 and 800 shares issued and outstanding as of December 31, 2023 and 2022, respectively.
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; 527,156,418,606 and 525,156,418,606 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS’ DEFICIT

TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

Comments